Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
06/07/1995 | EP0656014A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
06/07/1995 | EP0656013A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
06/07/1995 | EP0656012A1 T cell epitopes of ryegrass pollen allergen |
06/07/1995 | EP0656010A1 New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods |
06/07/1995 | EP0655926A1 New tumor diagnosing or therapeutical probe |
06/07/1995 | EP0655924A1 A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING |
06/07/1995 | EP0465652B1 Antibody against heavy chain of smooth muscle myosin |
06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
06/07/1995 | CN1103431A Determination of lymph nodes enriched in tumor reactive... |
06/06/1995 | US5422427 Pneumococcal fimbrial protein A |
06/06/1995 | US5422424 Antibiotic cryptdin peptides and methods of their use |
06/06/1995 | US5422284 Method of performing affinity separation using immobilized flocculating agent on chromatographic support |
06/06/1995 | US5422274 Internal deletion mutants of soluble T4(CD4) |
06/06/1995 | US5422264 Harvesting protein medium secreted by rat bladder carcinoma cells, then culturing epithelial cells in medium |
06/06/1995 | US5422258 Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils |
06/06/1995 | US5422249 Process for the manufacture of thrombin inhibitors |
06/06/1995 | US5422248 Clones having nucleotide sequence from human genes which code amino acid sequences and are active in binding to membranes, solids or whole cells |
06/06/1995 | US5422245 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for assay of the inhibitors |
06/06/1995 | US5422244 Detection of brain α1-antichymotrypsin |
06/06/1995 | US5422239 Sensitivity; purification of vital antigens |
06/06/1995 | US5422110 Enhanced immunogenicity using leukotoxin chimeras |
06/06/1995 | US5422094 19 F labelled antibodies and fragments thereof as NMR imaging and spectroscopy agents |
06/06/1995 | CA1335800C Synovial phospholipases |
06/06/1995 | CA1335797C Differential antigen, nda3, associated with the receptor for b cell growth factor |
06/06/1995 | CA1335796C Monoclonal antibodies and antigen for human non-small cell lung carcinomas |
06/06/1995 | CA1335792C Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease |
06/06/1995 | CA1335791C Immunoassay for human chromogranin a |
06/06/1995 | CA1335790C Influenza vaccine |
06/06/1995 | CA1335765C Whey protein fractions |
06/01/1995 | WO1995014930A1 Kinase receptor activation assay |
06/01/1995 | WO1995014780A2 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies |
06/01/1995 | WO1995014779A1 Mutated hig-e fragments and derivative thereof |
06/01/1995 | WO1995014778A2 Dna sequence coding for a bmp receptor |
06/01/1995 | WO1995014776A1 PROTEIN TYROSINE KINASES NAMED Rse |
06/01/1995 | WO1995014711A1 Cell adhesion molecules and detecting adherence |
06/01/1995 | WO1995014710A1 Chemically modified binding protein |
06/01/1995 | WO1995006732A3 Bacterial exported proteins and acellular vaccines based thereon |
06/01/1995 | WO1994025598A3 Methods and compositions for salmonella-based vaccines |
05/31/1995 | EP0655626A1 Diagnostic assays for Alzheimer's disease |
05/31/1995 | EP0655502A1 Cho cells transformed with a recombinant plasmid expressing human secreting type thyroid peroxidase and preparation thereof |
05/31/1995 | EP0655501A1 HIV-2 virus variants |
05/31/1995 | EP0557270B1 Cationized antibodies for delivery through the blood-brain barrier |
05/31/1995 | EP0362339B1 Use of a support with immobilized molecules or substances thereon |
05/31/1995 | CA2110213A1 Inhibition of dna metase for therapy |
05/30/1995 | US5420264 Non-human primate CD4 polypeptides, human CD4 molecules capable of glycosylation, fragments thereof, fusion proteins thereof, genetic sequences thereof, and the use thereof |
05/30/1995 | US5420263 Amplification of human MDM2 gene in human tumors |
05/30/1995 | US5420253 Method for purifying egg yolk immunoglobulins |
05/30/1995 | US5420251 Anti-idiotype antibodies specific for the parotope of antibodies which bind to IgE-bearing B cells but not basophils |
05/30/1995 | US5420247 Genetic engineering and expression vectors |
05/30/1995 | US5420028 Truncated human cholesterol 7α-hydroxylase, method of production and use thereof |
05/30/1995 | US5420019 Stable bactericidal/permeability-increasing protein muteins |
05/30/1995 | US5420012 Method for the detection of reactive conditions |
05/30/1995 | US5419906 Acidic, low temperature incubation |
05/30/1995 | US5419904 Human B-lymphoblastoid cell line secreting anti-ganglioside antibody |
05/30/1995 | CA1335720C Detection of necrotic malignant tissue and associated therapy |
05/26/1995 | WO1995014110A1 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
05/26/1995 | WO1995014093A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
05/26/1995 | WO1995014090A1 The human ep3 prostaglandin receptor |
05/26/1995 | WO1995014042A1 Antihuman tyrosinase monoclonal antibody |
05/26/1995 | WO1995014041A1 Reconstituted human antibody against human medulloblastomatous cell |
05/26/1995 | WO1995014040A1 Monoclonal antibodies specific for human interleukin-5 |
05/26/1995 | WO1995014039A1 Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (lbp) and methods of their use |
05/26/1995 | WO1995013831A1 Antibody to ocular and vaginal surface epithelium |
05/26/1995 | WO1995013827A1 A method for preventing or controlling cataract |
05/26/1995 | WO1995013821A1 αvβ3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS |
05/26/1995 | WO1995013701A1 Novel fas protein and methods of use thereof |
05/26/1995 | CA2176575A1 Novel fas protein and methods of use thereof |
05/26/1995 | CA2175374A1 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
05/24/1995 | EP0654532A1 Antimucoglycoprotein monoclonal antibody |
05/24/1995 | EP0654531A1 ADP glucose-pyrophosphorylase |
05/24/1995 | EP0654144A1 Immunochemical assays for cancer-associated scm recognition factor |
05/24/1995 | EP0654092A1 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
05/24/1995 | EP0654082A1 CLONING AND EXPRESSION OF A HUMAN $g(a)(1,3)FUCOSYLTRANSFERASE, FUCT-VI |
05/24/1995 | EP0654080A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE |
05/24/1995 | EP0653942A1 Morphogen-induced nerve regeneration and repair |
05/24/1995 | EP0653940A1 Glial mitogenic factors, their preparation and use |
05/24/1995 | EP0604560A4 Human cyclin e. |
05/24/1995 | EP0574394B1 Substances of polypeptide nature useful in human therapy |
05/24/1995 | EP0548194B1 Monoclonal antibody active against the interleukin-2 receptor |
05/24/1995 | EP0401370B1 Enzyme immunoassay according to sandwich method of human iv-type collagen |
05/24/1995 | EP0357767B1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
05/24/1995 | DE3690028C2 Method and test kit for analysing a biological sample for antibodies against retroviruses |
05/23/1995 | US5418157 Recombinant 68,000 dalton collagenase of Clostridium histolyticum |
05/23/1995 | US5418147 Glycosyl-phosphatidylinositol-specific phospholipase D |
05/23/1995 | US5418129 Antitumor |
05/23/1995 | US5417972 Method of killing B-cells in a complement independent and an ADCC independent manner using antibodies which specifically bind CDIM |
05/23/1995 | CA1335656C Luminescent chimeric proteins |
05/23/1995 | CA1335655C Vaccines and diagnostic assays for haemophilus influenzae |
05/23/1995 | CA1335654C Monoclonal antibodies capable of recognizing gangliosides go__ and gt |
05/23/1995 | CA1335653C Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
05/18/1995 | WO1995013370A1 Haemophilus transferrin receptor genes |
05/18/1995 | WO1995013363A1 Hematopoietic stem cells from swine cord blood and uses thereof |
05/18/1995 | WO1995013294A1 Cytokines from natural killer or t cells |
05/18/1995 | WO1995013293A1 Fas LIGAND, PART THEREOF, AND DNA CODING FOR THE SAME |
05/18/1995 | WO1995013292A1 Bcl-2-associated proteins |
05/18/1995 | WO1995013103A2 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells |
05/18/1995 | WO1995013094A1 Treatment of bacterially-induced inflammatory diseases |
05/18/1995 | WO1995013093A1 Treatment of a patient prior to transplantation |
05/18/1995 | WO1995013089A1 Compositions and method for stimulating antibody release by b lymphocytes |
05/18/1995 | WO1995013084A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |